Machine Learning Models to Predict Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) With Simple Anthropometric and Biochemical Variables: A Cross‐Sectional Study in US Population
International Journal of Hepatology · 2026-01 · 2026 (1)
DOI: 10.1155/ijh/8221645 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Hepatology, online erschienen am 01.04.2026. Verfasst von Shiying Du und 3 weiteren Autor:innen. Beteiligte Einrichtung: Comprehensive Supervision and Service Center of Hebei Health Commission, Shijiazhuang, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is an emerging global health concern. This study was aimed at exploring the feasibility of utilizing machine learning (ML) algorithms to predict MASLD in large general populations based on simple anthropometric and biochemical parameters.
Methods
Data from the 2017–2020 cycles of the US National Health and Nutrition Examination Survey (NHANES) were utilized. A total of 6814 participants (53.0% female) with complete transient elastography data were included. MASLD was defined as a controlled attenuation parameter ≥ 280 dB/m, with cardiometabolic risk factor and without excessive alcohol use. Key characteristics and biomarkers associated with MASLD were identified using the least absolute shrinkage and selection operator (LASSO) and the Boruta algorithms. ML methods, including logistic regression (LR), extreme gradient boosting (XGBoost), bootstrap aggregating, random forest, naive Bayes, light gradient boosting machine (LightGBM), decision tree, and support vector machines, were employed to develop the MASLD prediction models.
Results
The median age of the 6814 participants was 53 years (interquartile range: 37~65). MASLD was detected among 2611 (38.3%) participants. Key predictors selected via LASSO and Boruta algorithms included body weight, standing height, waist circumference, diagnosis of diabetes, alanine aminotransferase, aspartate aminotransferase, and gamma glutamyl transferase. The areas under the receiver operating characteristic curves of LR, XGBoost, and other ML models were 0.841, 0.837, 0.815, 0.838, 0.814, 0.842, 0.796, and 0.828 in the internal validation cohort. Results indicate that LR, XGBoost, and LightGBM models outperform other models in predicting MASLD.
Conclusions
The ML models of LR, XGBoost, and LightGBM are effective and simplified tools for predicting MASLD in the US general population. This study underscores the potential of ML models with simple noninvasive biomarkers in enhancing early detection and personalized management of fatty liver disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Comprehensive Supervision and Service Center of Hebei Health Commission, Shijiazhuang, China.
- Department of Medicine, Beijing Kawin Technology Share-Holding Co. Ltd, Beijing, China.
- Department of Medical Research, The First Affiliated Hospital of Guangxi Medical University, Nanning, China, gxmu.edu.cn.
ORCID-Profile: Shiying Du, Hailiang Yu, Jianbo Du, Yunan Xu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Du, S., Yu, H., Du, J., & Xu, Y. (2026). Machine Learning Models to Predict Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) With Simple Anthropometric and Biochemical Variables: A Cross‐Sectional Study in US Population. International Journal of Hepatology, 2026(1). https://doi.org/10.1155/ijh/8221645
Vancouver
Du S, Yu H, Du J, Xu Y. Machine Learning Models to Predict Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) With Simple Anthropometric and Biochemical Variables: A Cross‐Sectional Study in US Population. International Journal of Hepatology. 2026;2026(1). doi:10.1155/ijh/8221645
BibTeX
@article{Du2026,
author = {Du, Shiying and Yu, Hailiang and Du, Jianbo and Xu, Yunan},
title = {Machine Learning Models to Predict Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD) With Simple Anthropometric and Biochemical Variables: A Cross‐Sectional Study in US Population},
journal = {International Journal of Hepatology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijh/8221645}
}
EUVIMED